Mosquirix is a recombinant protein-based vaccine that targets the circumsporozoite protein (CSP) of Plasmodium falciparum. It works by stimulating the immune system to produce antibodies and T-cells that can attack the malaria parasite before it infects the liver, where it can mature and multiply.
